Disruption of mgrB gene by ISkpn14 sourced from a bla


Journal

BMC microbiology
ISSN: 1471-2180
Titre abrégé: BMC Microbiol
Pays: England
ID NLM: 100966981

Informations de publication

Date de publication:
22 Oct 2024
Historique:
received: 10 03 2024
accepted: 08 10 2024
medline: 23 10 2024
pubmed: 23 10 2024
entrez: 22 10 2024
Statut: epublish

Résumé

Carbapenem-resistant Klebsiella pneumoniae (CRKP) infections poses global challenges, with limited options available for targeted therapy. Polymyxin was been regarded as one of the most important last-resort antimicrobial agents. Many factors could accelerate the resistance evolution of polymyxin. Insertion sequence (IS) inserted into mgrB is the main polymyxin resistance mechanism in K. pneumoniae. In this study, two CRKPs (KP31157 and KP31311) were isolated from the urine of a patient, shifting from susceptible to resistant as the mgrB inserted by ISkpn14. We intended to explore the origin of the IS and underlying mechanisms resulting in polymyxin resistance. The within-host evolution relationship and molecular features of both CRKPs were determined by pulsed-field gel electrophoresis (PFGE) and whole-genome sequencing (WGS). pKP31311_KPC-2 plasmid genome structures contained in the above two CRKPs were aligned with the homologic plasmids, retrieved from the NCBI genome database via comparative genomic analysis. The plasmids encoding ISkpn14 elements flanked by direct repeat (DR) or not were analyzed. The mRNA expression, plasmid curing and in vitro antibiotics inducing experiment were employed to understand the potential mechanism of polymyxin resistance. Both strains, sharing homology, exhibited polymyxin resistance due to the insertion of ISkpn14 into the mgrB gene, influenced by minocycline exposure. Minocycline and tigecycline could accelerate polymyxin resistance (P < 0.05), validated by an in vitro induction experiment. The ISkpn14 without DR flanked expressed about 4 times higher than that with DR. The frequency of the mgrB insertion induced by polymyxin was significantly reduced (0 strain detected) after the bla This study provides direct experimental evidence that the ISkpn14 element causing mgrB inactivation and polymyxin resistance in K. pneumoniae originates from bla

Sections du résumé

BACKGROUND BACKGROUND
Carbapenem-resistant Klebsiella pneumoniae (CRKP) infections poses global challenges, with limited options available for targeted therapy. Polymyxin was been regarded as one of the most important last-resort antimicrobial agents. Many factors could accelerate the resistance evolution of polymyxin. Insertion sequence (IS) inserted into mgrB is the main polymyxin resistance mechanism in K. pneumoniae. In this study, two CRKPs (KP31157 and KP31311) were isolated from the urine of a patient, shifting from susceptible to resistant as the mgrB inserted by ISkpn14. We intended to explore the origin of the IS and underlying mechanisms resulting in polymyxin resistance.
METHODS METHODS
The within-host evolution relationship and molecular features of both CRKPs were determined by pulsed-field gel electrophoresis (PFGE) and whole-genome sequencing (WGS). pKP31311_KPC-2 plasmid genome structures contained in the above two CRKPs were aligned with the homologic plasmids, retrieved from the NCBI genome database via comparative genomic analysis. The plasmids encoding ISkpn14 elements flanked by direct repeat (DR) or not were analyzed. The mRNA expression, plasmid curing and in vitro antibiotics inducing experiment were employed to understand the potential mechanism of polymyxin resistance.
RESULTS RESULTS
Both strains, sharing homology, exhibited polymyxin resistance due to the insertion of ISkpn14 into the mgrB gene, influenced by minocycline exposure. Minocycline and tigecycline could accelerate polymyxin resistance (P < 0.05), validated by an in vitro induction experiment. The ISkpn14 without DR flanked expressed about 4 times higher than that with DR. The frequency of the mgrB insertion induced by polymyxin was significantly reduced (0 strain detected) after the bla
CONCLUSIONS CONCLUSIONS
This study provides direct experimental evidence that the ISkpn14 element causing mgrB inactivation and polymyxin resistance in K. pneumoniae originates from bla

Identifiants

pubmed: 39438834
doi: 10.1186/s12866-024-03572-2
pii: 10.1186/s12866-024-03572-2
doi:

Substances chimiques

Polymyxins 0
Anti-Bacterial Agents 0
beta-Lactamases EC 3.5.2.6
Carbapenems 0
Bacterial Proteins 0
DNA Transposable Elements 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

422

Subventions

Organisme : Beijing Natural Science Foundation
ID : 7242124
Organisme : The CAMS Innovation Fund for Medical Sciences
ID : CIFMS; No.2021-I2M-1-030

Informations de copyright

© 2024. The Author(s).

Références

Wang Q, Wang X, Wang J, Ouyang P, Jin C, Wang R, et al. Phenotypic and genotypic characterization of Carbapenem-resistant Enterobacteriaceae: data from a longitudinal large-scale CRE Study in China (2012–2016). Clin Infect Dis. 2018;67(suppl2):S196–205. https://doi.org/10.1093/cid/ciy660 .
doi: 10.1093/cid/ciy660 pubmed: 30423057
Poirel L, Jayol A, Nordmann P, Polymyxins. Antibacterial activity, susceptibility testing, and Resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev. 2017;30(2):557–96. https://doi.org/10.1128/CMR.00064-16 .
doi: 10.1128/CMR.00064-16 pubmed: 28275006 pmcid: 5355641
Naha S, Sands K, Mukherjee S, Dutta S, Basu S. A 12 year experience of colistin resistance in Klebsiella pneumoniae causing neonatal sepsis: two-component systems, efflux pumps, lipopolysaccharide modification and comparative phylogenomics. J Antimicrob Chemother. 2022;77(6):1586–91. https://doi.org/10.1093/jac/dkac083 .
doi: 10.1093/jac/dkac083 pubmed: 35323923
Li ZLX, Lei Z, Li C, Zhang F, Wu Y, Yang X, Zhao J, Zhang Y, Hu Y, Shen F, Wang P, Yang J, Liu Y, Lu B. Genetic diversity of polymyxin-resistance mechanisms in clinical isolates of Carbapenem-resistant Klebsiella pneumoniae: a Multicenter Study in China. Microbiol Spectr. 2023;e0523122. https://doi.org/10.1128/spectrum.05231-22 .
El-Sayed Ahmed MAE-G, Zhong L-L, Shen C, Yang Y, Doi Y, Tian G-B. Colistin and its role in the era of antibiotic resistance: an extended review (2000–2019). Emerg Microbes Infect. 2020;9(1):868–85. https://doi.org/10.1080/22221751.2020.1754133 .
doi: 10.1080/22221751.2020.1754133 pubmed: 32284036 pmcid: 7241451
Lippa AM, Goulian M. Feedback inhibition in the PhoQ/PhoP signaling system by a membrane peptide. PLoS Genet. 2009;5(12):e1000788. https://doi.org/10.1371/journal.pgen.1000788 .
doi: 10.1371/journal.pgen.1000788 pubmed: 20041203 pmcid: 2789325
Shankar C, Pragasam AK, Anandan S, Veeraraghavan B. As Hotspot for insertion sequence integration: Change over from Multidrug-resistant to extensively drug-resistant ? Microb Drug Resist. 2019;25(7):1122–5. https://doi.org/10.1089/mdr.2018.0415 .
doi: 10.1089/mdr.2018.0415 pubmed: 30946628
Berglund B, Hoang NTB, Tärnberg M, Le NK, Svartström O, Khu DTK, et al. Insertion sequence transpositions and point mutations in mgrB causing colistin resistance in a clinical strain of carbapenem-resistant Klebsiella pneumoniae from Vietnam. Int J Antimicrob Agents. 2018;51(5):789–93. https://doi.org/10.1016/j.ijantimicag.2017.11.012 .
doi: 10.1016/j.ijantimicag.2017.11.012 pubmed: 29180281
Cannatelli A, Giani T, D’Andrea MM, Di Pilato V, Arena F, Conte V, et al. MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin. Antimicrob Agents Chemother. 2014;58(10):5696–703. https://doi.org/10.1128/AAC.03110-14 .
doi: 10.1128/AAC.03110-14 pubmed: 25022583 pmcid: 4187966
Fordham SME, Mantzouratou A, Sheridan E. Prevalence of insertion sequence elements in plasmids relating to mgrB gene disruption causing colistin resistance in Klebsiella pneumoniae. Microbiologyopen. 2022;11(1):e1262. https://doi.org/10.1002/mbo3.1262 .
doi: 10.1002/mbo3.1262 pubmed: 35212479 pmcid: 8796155
Zhang Y, Wang X, Wang S, Sun S, Li H, Chen H, et al. Emergence of Colistin Resistance in Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae under the pressure of Tigecycline. Front Microbiol. 2021;12:756580. https://doi.org/10.3389/fmicb.2021.756580 .
doi: 10.3389/fmicb.2021.756580 pubmed: 34925264 pmcid: 8672221
Zhao J, Li Z, Zhang Y, Liu X, Lu B, Cao B. Convergence of MCR-8.2 and chromosome-mediated resistance to Colistin and Tigecycline in an NDM-5-Producing ST656 Klebsiella pneumoniae isolate from a lung transplant patient in China. Front Cell Infect Microbiol. 2022;12:922031. https://doi.org/10.3389/fcimb.2022.922031 .
doi: 10.3389/fcimb.2022.922031 pubmed: 35899054 pmcid: 9310643
CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 33th Edition: M100. 2023.
Hong YK, Kim H, Ko KS. Two types of colistin heteroresistance in Acinetobacter baumannii isolates. Emerg Microbes Infect. 2020;9(1):2114–23. https://doi.org/10.1080/22221751.2020.1821584 .
doi: 10.1080/22221751.2020.1821584 pubmed: 32897166 pmcid: 7534296
Machuca J, Lopez-Cerero L, Rodríguez-Maresca M, Fernández-Cuenca F, López-Hernández I, Delgado-Valverde M, et al. Molecular characterisation of an outbreak of NDM-7-producing Klebsiella pneumoniae reveals ST11 clone expansion combined with interclonal plasmid dissemination. Int J Antimicrob Agents. 2022;59(4):106551. https://doi.org/10.1016/j.ijantimicag.2022.106551 .
doi: 10.1016/j.ijantimicag.2022.106551 pubmed: 35176478
Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33(9):2233–9.
doi: 10.1128/jcm.33.9.2233-2239.1995 pubmed: 7494007 pmcid: 228385
Li R, Zhu H, Ruan J, Qian W, Fang X, Shi Z, et al. De novo assembly of human genomes with massively parallel short read sequencing. Genome Res. 2010;20(2):265–72. https://doi.org/10.1101/gr.097261.109 .
doi: 10.1101/gr.097261.109 pubmed: 20019144 pmcid: 2813482
Li R, Li Y, Kristiansen K, Wang J. SOAP: short oligonucleotide alignment program. Bioinformatics. 2008;24(5):713–4. https://doi.org/10.1093/bioinformatics/btn025 .
doi: 10.1093/bioinformatics/btn025 pubmed: 18227114
Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19(5):455–77. https://doi.org/10.1089/cmb.2012.0021 .
doi: 10.1089/cmb.2012.0021 pubmed: 22506599 pmcid: 3342519
Simpson JT, Wong K, Jackman SD, Schein JE, Jones SJM, Birol I. ABySS: a parallel assembler for short read sequence data. Genome Res. 2009;19(6):1117–23. https://doi.org/10.1101/gr.089532.108 .
doi: 10.1101/gr.089532.108 pubmed: 19251739 pmcid: 2694472
Wick RR, Judd LM, Gorrie CL, Holt KE, Unicycler. Resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol. 2017;13(6):e1005595. https://doi.org/10.1371/journal.pcbi.1005595 .
doi: 10.1371/journal.pcbi.1005595 pubmed: 28594827 pmcid: 5481147
Lin S-H, Liao Y-C. CISA: contig integrator for sequence assembly of bacterial genomes. PLoS ONE. 2013;8(3):e60843. https://doi.org/10.1371/journal.pone.0060843 .
doi: 10.1371/journal.pone.0060843 pubmed: 23556006 pmcid: 3610655
Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30(14):2068–9. https://doi.org/10.1093/bioinformatics/btu153 .
doi: 10.1093/bioinformatics/btu153 pubmed: 24642063
Siguier P, Perochon J, Lestrade L, Mahillon J, Chandler M. ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res. 2006;34(Database issue):D32–6.
doi: 10.1093/nar/gkj014 pubmed: 16381877
Wei D, Wang M, Shi J, Hao J. Red recombinase assisted gene replacement in Klebsiella pneumoniae. J Ind Microbiol Biotechnol. 2012;39(8):1219–26. https://doi.org/10.1007/s10295-012-1117-x .
doi: 10.1007/s10295-012-1117-x pubmed: 22430500
Ruzin A, Visalli MA, Keeney D, Bradford PA. Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2005;49(3):1017–22.
doi: 10.1128/AAC.49.3.1017-1022.2005 pubmed: 15728897 pmcid: 549240
Kang J, Park M, Lee E, Jung J, Kim T. The Role of Vitamin D in Alzheimer’s Disease: A Transcriptional Regulator of Amyloidopathy and Gliopathy. Biomedicines. 2022;10(8). https://doi.org/10.3390/biomedicines10081824 .
Yang X, Dong N, Liu X, Yang C, Ye L, Chan EW-C, et al. Co-conjugation of virulence plasmid and KPC plasmid in a clinical strain. Front Microbiol. 2021;12:739461. https://doi.org/10.3389/fmicb.2021.739461 .
doi: 10.3389/fmicb.2021.739461 pubmed: 34819921 pmcid: 8606748
van Duin D, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence. 2017;8(4):460–9. https://doi.org/10.1080/21505594.2016.1222343 .
doi: 10.1080/21505594.2016.1222343 pubmed: 27593176
Moon S, Kang J, Kim SH, Chung HS, Kim YJ, Yu JM, et al. Beneficial effects of Time-restricted eating on metabolic diseases: a systemic review and Meta-analysis. Nutrients. 2020;12(5). https://doi.org/10.3390/nu12051267 .
Andrade FF, Silva D, Rodrigues A, Pina-Vaz C. Colistin Update on its mechanism of Action and Resistance, Present and Future challenges. Microorganisms. 2020;8(11). https://doi.org/10.3390/microorganisms8111716 .
Drozdinsky G, Ben-Zvi H, Kushnir S, Leibovici L, Yahav D. Colistin exposure as a risk factor for infections caused by inherently colistin resistant Enterobacteriaceae-a case-control study. Clin Microbiol Infect. 2018;24(8):896–9. https://doi.org/10.1016/j.cmi.2017.11.022 .
doi: 10.1016/j.cmi.2017.11.022 pubmed: 29217278
Zhang X, Qu F, Jia W, Huang B, Shan B, Yu H, et al. Polymyxin resistance in carbapenem-resistant Enterobacteriaceae isolates from patients without polymyxin exposure: a multicentre study in China. Int J Antimicrob Agents. 2021;57(2):106262. https://doi.org/10.1016/j.ijantimicag.2020.106262 .
doi: 10.1016/j.ijantimicag.2020.106262 pubmed: 33347990
Silva DMd, Faria-Junior C, Nery DR, Oliveira PMd, Silva LOR, Alves EG, et al. Insertion sequences disrupting mgrB in carbapenem-resistant Klebsiella pneumoniae strains in Brazil. J Global Antimicrob Resist. 2021;24:53–7. https://doi.org/10.1016/j.jgar.2020.11.003 .
doi: 10.1016/j.jgar.2020.11.003
Yang T-Y, Wang S-F, Lin J-E, Griffith BTS, Lian S-H, Hong Z-D, et al. Contributions of insertion sequences conferring colistin resistance in Klebsiella pneumoniae. Int J Antimicrob Agents. 2020;55(3):105894. https://doi.org/10.1016/j.ijantimicag.2020.105894 .
doi: 10.1016/j.ijantimicag.2020.105894 pubmed: 31923567
Huang P-H, Cheng Y-H, Chen W-Y, Juan C-H, Chou S-H, Wang J-T, et al. Risk factors and mechanisms of in vivo emergence of colistin resistance in carbapenem-resistant Klebsiella pneumoniae. Int J Antimicrob Agents. 2021;57(6):106342. https://doi.org/10.1016/j.ijantimicag.2021.106342 .
doi: 10.1016/j.ijantimicag.2021.106342 pubmed: 33864932
Zhu Y, Galani I, Karaiskos I, Lu J, Aye SM, Huang J, et al. Multifaceted mechanisms of colistin resistance revealed by genomic analysis of multidrug-resistant Klebsiella pneumoniae isolates from individual patients before and after colistin treatment. J Infect. 2019;79(4):312–21. https://doi.org/10.1016/j.jinf.2019.07.009 .
doi: 10.1016/j.jinf.2019.07.009 pubmed: 31374222 pmcid: 7264071
Mahillon J, Chandler M. Insertion sequences. Microbiol Mol Biol Rev. 1998;62(3):725–74. https://doi.org/10.1128/mmbr.62.3.725-774.1998. 
doi: 10.1128/MMBR.62.3.725-774.1998 pubmed: 9729608 pmcid: 98933
Zhang B, Yu B, Zhou W, Wang Y, Sun Z, Wu X, et al. Mobile plasmid mediated transition from colistin-sensitive to resistant phenotype in. Front Microbiol. 2021;12:619369. https://doi.org/10.3389/fmicb.2021.619369 .
doi: 10.3389/fmicb.2021.619369 pubmed: 33658985 pmcid: 7917065

Auteurs

Ziyao Li (Z)

Laboratory of Clinical Microbiology and Infectious Diseases, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, China-Japan Friendship Hospital, No. 2 East Yinghua Street, Beijing, Chaoyang, 100029, China.
National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
China-Japan Friendship Institute of Clinical Medical Sciences, Beijing, China.
Changping Laboratory, Beijing, China.

Zichen Lei (Z)

Laboratory of Clinical Microbiology and Infectious Diseases, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, China-Japan Friendship Hospital, No. 2 East Yinghua Street, Beijing, Chaoyang, 100029, China.
National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
China-Japan Friendship Institute of Clinical Medical Sciences, Beijing, China.

Xinmeng Liu (X)

Laboratory of Clinical Microbiology and Infectious Diseases, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, China-Japan Friendship Hospital, No. 2 East Yinghua Street, Beijing, Chaoyang, 100029, China.
National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China.

Feilong Zhang (F)

Laboratory of Clinical Microbiology and Infectious Diseases, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, China-Japan Friendship Hospital, No. 2 East Yinghua Street, Beijing, Chaoyang, 100029, China.
National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China.

Xinrui Yang (X)

Laboratory of Clinical Microbiology and Infectious Diseases, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, China-Japan Friendship Hospital, No. 2 East Yinghua Street, Beijing, Chaoyang, 100029, China.
National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

Yongli Wu (Y)

Laboratory of Clinical Microbiology and Infectious Diseases, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, China-Japan Friendship Hospital, No. 2 East Yinghua Street, Beijing, Chaoyang, 100029, China.
National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

Chen Li (C)

Laboratory of Clinical Microbiology and Infectious Diseases, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, China-Japan Friendship Hospital, No. 2 East Yinghua Street, Beijing, Chaoyang, 100029, China.
National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China.
Liuyang Traditional Chinese Medicine Hospital, Changsha, Hunan, China.

Jiankang Zhao (J)

Laboratory of Clinical Microbiology and Infectious Diseases, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, China-Japan Friendship Hospital, No. 2 East Yinghua Street, Beijing, Chaoyang, 100029, China.
National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.

Yulin Zhang (Y)

Laboratory of Clinical Microbiology and Infectious Diseases, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, China-Japan Friendship Hospital, No. 2 East Yinghua Street, Beijing, Chaoyang, 100029, China.
National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.

Yanning Hua (Y)

Laboratory of Clinical Microbiology and Infectious Diseases, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, China-Japan Friendship Hospital, No. 2 East Yinghua Street, Beijing, Chaoyang, 100029, China.
National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China.

Binghuai Lu (B)

Laboratory of Clinical Microbiology and Infectious Diseases, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, China-Japan Friendship Hospital, No. 2 East Yinghua Street, Beijing, Chaoyang, 100029, China. zs25041@126.com.
National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China. zs25041@126.com.
Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. zs25041@126.com.
China-Japan Friendship Institute of Clinical Medical Sciences, Beijing, China. zs25041@126.com.
Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China. zs25041@126.com.

Bin Cao (B)

Laboratory of Clinical Microbiology and Infectious Diseases, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, China-Japan Friendship Hospital, No. 2 East Yinghua Street, Beijing, Chaoyang, 100029, China. caobin_ben@163.com.
National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China. caobin_ben@163.com.
Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. caobin_ben@163.com.
China-Japan Friendship Institute of Clinical Medical Sciences, Beijing, China. caobin_ben@163.com.
Changping Laboratory, Beijing, China. caobin_ben@163.com.
Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China. caobin_ben@163.com.
Tsinghua University-Peking University Joint Center for Life Sciences, Beijing, China. caobin_ben@163.com.
Department of Respiratory Medicine, Capital Medical University, Beijing, China. caobin_ben@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH